Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

NCT01978977 · clinicaltrials.gov ↗
COMPLETED
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Hellenic Oncology Research Group